Replies to post #68952 on Biotech Values

[DewDiligence]

Re: INFORM-1 all-oral HCV trial

>If the second cohort is dosing lo/high for the Protease and Polymerase, is there any reason why they wouldn't do 2 cohorts simultaneously (i.e. lo/high Protease-Polymerase and lo-high for Polymerase and Protease).<

There is no reason I can think of why Roche would not do what you said.